High-risk people

Last updated
Elisabeth Steubesand, 105 years old, the oldest citizen of Cologne and a high-risk individual COVID-19 vaccination center, fair grounds Cologne, 1st vaccination-8070.jpg
Elisabeth Steubesand, 105 years old, the oldest citizen of Cologne and a high-risk individual

A high-risk individual, high-risk person, or high-risk population is a human being or beings living with an increased risk for severe illness due to age, medical condition, pregnancy/post-pregnant conditions, geographical location, or a combination of these risk factors. [1]

Contents

High-risk people qualification

High-risk people can be of any age. [2] High-risk populations are vulnerable to serious illness. [3] Globally, societal factors including limited access to healthcare and inadequate hygiene facilities can result in high-risk individuals. [3] [4] [5] Access to proper healthcare is essential to the health and treatment of high-risk individuals, particularly high-risk mothers and infants. [3] High-risk individuals can require long-term care. [3]

In immunology, a person qualifies as a high-risk individual if their immune system is compromised or suppressed whether due to disease, cancer, chronic conditions, prescription medications, or recent surgical procedures. [6] [7] [8] High-risk people are more susceptible to hospitalization and death from the Coronavirus disease 2019. [9] The Centers for Disease Control and Prevention (CDC) recommends high-risk persons get the COVID-19 vaccine. [10] [9]

In psychiatry, a high-risk individual is a patient who engages in high-risk behaviors. [11] In addiction treatment lexicon, a high-risk person refers to a person with a high likelihood of addiction and/or high likelihood of relapse. [12]

Criteria for COVID-19

Risk factors that have been cited in the United States as defining high-risk individuals for suffering the more serious symptoms of COVID-19 include: [13] [14]

See also

Related Research Articles

<span class="mw-page-title-main">Mpox</span> Viral disease of humans and animals

Mpox is an infectious viral disease that can occur in humans and other animals. Symptoms include a rash that forms blisters and then crusts over, fever, and swollen lymph nodes. The illness is usually mild, and most infected individuals recover within a few weeks without treatment. The time from exposure to the onset of symptoms ranges from three to seventeen days, and symptoms typically last from two to four weeks. However, cases may be severe, especially in children, pregnant women, or people with suppressed immune systems.

<span class="mw-page-title-main">Fifth disease</span> Red rash due to infection with parvovirus B19

Fifth disease, also known as erythema infectiosum and slapped cheek syndrome, is a common and contagious disease caused by infection with parvovirus B19. This virus was discovered in 1975 and can cause other diseases besides fifth disease. Fifth disease typically presents as a rash and is most common in children. While parvovirus B19 can affect people of all ages, only two out of ten individuals will present with symptoms.

<span class="mw-page-title-main">Maternal death</span> Aspect of human reproduction and medicine

Maternal death or maternal mortality is defined in slightly different ways by several different health organizations. The World Health Organization (WHO) defines maternal death as the death of a pregnant mother due to complications related to pregnancy, underlying conditions worsened by the pregnancy or management of these conditions. This can occur either while she is pregnant or within six weeks of resolution of the pregnancy. The CDC definition of pregnancy-related deaths extends the period of consideration to include one year from the resolution of the pregnancy. Pregnancy associated death, as defined by the American College of Obstetricians and Gynecologists (ACOG), are all deaths occurring within one year of a pregnancy resolution. Identification of pregnancy associated deaths is important for deciding whether or not the pregnancy was a direct or indirect contributing cause of the death.

<span class="mw-page-title-main">DPT vaccine</span> Combination vaccine

The DPT vaccine or DTP vaccine is a class of combination vaccines to protect against three infectious diseases in humans: diphtheria, pertussis, and tetanus (lockjaw). The vaccine components include diphtheria and tetanus toxoids, and either killed whole cells of the bacterium that causes pertussis or pertussis antigens. The term toxoid refers to vaccines which use an inactivated toxin produced by the pathogen which they are targeted against to generate an immune response. In this way, the toxoid vaccine generates an immune response which is targeted against the toxin which is produced by the pathogen and causes disease, rather than a vaccine which is targeted against the pathogen itself. The whole cells or antigens will be depicted as either "DTwP" or "DTaP", where the lower-case "w" indicates whole-cell inactivated pertussis and the lower-case "a" stands for "acellular". In comparison to alternative vaccine types, such as live attenuated vaccines, the DTP vaccine does not contain any live pathogen, but rather uses inactivated toxoid to generate an immune response; therefore, there is not a risk of use in populations that are immune compromised since there is not any known risk of causing the disease itself. As a result, the DTP vaccine is considered a safe vaccine to use in anyone and it generates a much more targeted immune response specific for the pathogen of interest.

Post-exposure prophylaxis, also known as post-exposure prevention (PEP), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring.

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza: winners drink Tamiflu

Oseltamivir, sold under the brand name Tamiflu among others, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots or the flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

<span class="mw-page-title-main">Sexual and reproductive health</span> State of the reproductive system without evidence of disease, disorders, or deficiencies

Sexual and reproductive health (SRH) is a field of research, health care, and social activism that explores the health of an individual's reproductive system and sexual well-being during all stages of their life. Sexual and reproductive health is more commonly defined as sexual and reproductive health and rights, to encompass individual agency to make choices about their sexual and reproductive lives.

A health professional, healthcare professional, or healthcare worker is a provider of health care treatment and advice based on formal training and experience. The field includes those who work as a nurse, physician, physician assistant, registered dietitian, veterinarian, veterinary technician, optometrist, pharmacist, pharmacy technician, medical assistant, physical therapist, occupational therapist, dentist, midwife, psychologist, audiologist, or healthcare scientist, or who perform services in allied health professions. Experts in public health and community health are also health professionals.

<span class="mw-page-title-main">Varicella vaccine</span> Vaccine to prevent chickenpox

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine are more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin. Another vaccine, known as zoster vaccine, is used to prevent diseases caused by the same virus – the varicella zoster virus.

<span class="mw-page-title-main">Chickenpox</span> Human viral disease

Chickenpox, also known as varicella, is a highly contagious, vaccine-preventable disease caused by the initial infection with varicella zoster virus (VZV), a member of the herpesvirus family. The disease results in a characteristic skin rash that forms small, itchy blisters, which eventually scab over. It usually starts on the chest, back, and face. It then spreads to the rest of the body. The rash and other symptoms, such as fever, tiredness, and headaches, usually last five to seven days. Complications may occasionally include pneumonia, inflammation of the brain, and bacterial skin infections. The disease is usually more severe in adults than in children.

<span class="mw-page-title-main">Refugee health</span> Health effects experienced by people who have been displaced

Refugee health is the field of study on the health effects experienced by people who have been displaced into another country or even to another part of the world, as a result of unsafe circumstances such as war or persecution. People who have been displaced can be affected by infectious diseases or some chronic diseases that are uncommon in the country in which they eventually settle. Mental health is an important consideration and can greatly impact people who are displaced. The health status of refugee's can be tied to factors such as the person who migrated's geographic origin, conditions of refugee camps or urban settings where they lived, and personal, physical, and psychological conditions of the person, either pre-existing or acquired while traveling from their homeland to a camp or eventually to their new home.

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.

Infectious diseases within American correctional settings are a concern within the public health sector. The corrections population is susceptible to infectious diseases through exposure to blood and other bodily fluids, drug injection, poor health care, prison overcrowding, demographics, security issues, lack of community support for rehabilitation programs, and high-risk behaviors. The spread of infectious diseases, such as HIV and other sexually transmitted infections, hepatitis C (HCV), hepatitis B (HBV), and tuberculosis, result largely from needle-sharing, drug use, and consensual and non-consensual sex among prisoners. HIV and hepatitis C need specific attention because of the specific public health concerns and issues they raise.

<span class="mw-page-title-main">Maternal mortality in the United States</span> Overview of maternal mortality in the United States

Maternal mortality refers to the death of a woman during her pregnancy or up to a year after her pregnancy has terminated; this metric only includes causes related to the pregnancy, and does not include accidental causes. Some sources will define maternal mortality as the death of a woman up to 42 days after the pregnancy has ended, instead of one year. In 1986, the CDC began tracking pregnancy-related deaths to gather information and determine what was causing these deaths by creating the Pregnancy-Related Mortality Surveillance System. According to a 2010–2011 report although the United States was spending more on healthcare than any other country in the world, more than two women died during childbirth every day, making maternal mortality in the United States the highest when compared to 49 other countries in the developed world.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The disease spread worldwide, resulting in the COVID-19 pandemic.

<span class="mw-page-title-main">Workplace hazard controls for COVID-19</span> Prevention measures for COVID-19

Hazard controls for COVID-19 in workplaces are the application of occupational safety and health methodologies for hazard controls to the prevention of COVID-19. Multiple layers of controls are recommended, including measures such as remote work and flextime, personal protective equipment (PPE) and face coverings, social distancing, and enhanced cleaning programs. Recently, engineering controls have been emphasized, particularly stressing the importance of HVAC systems meeting a minimum of 5 air changes per hour with ventilation or MERV-13 filters, as well as the installation of UVGI systems in public areas.

<span class="mw-page-title-main">Mental health during the COVID-19 pandemic</span> Psychological aspect of viral outbreak

The COVID-19 pandemic has impacted the mental health of people across the globe. The pandemic has caused widespread anxiety, depression, and post-traumatic stress disorder symptoms. According to the UN health agency WHO, in the first year of the COVID-19 pandemic, prevalence of common mental health conditions, such as depression and anxiety, went up by more than 25 percent. The pandemic has damaged social relationships, trust in institutions and in other people, has caused changes in work and income, and has imposed a substantial burden of anxiety and worry on the population. Women and young people face the greatest risk of depression and anxiety. According to The Centers for Disease Control and Prevention study of Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic, "63 percent of young people reported experiencing substantial symptoms of anxiety and depression".

In epidemiology, a non-pharmaceutical intervention (NPI) is any method used to reduce the spread of an epidemic disease without requiring pharmaceutical drug treatments. Examples of non-pharmaceutical interventions that reduce the spread of infectious diseases include wearing a face mask and staying away from sick people.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on people with disabilities</span>

Individuals with disabilities are more susceptible to contracting COVID-19 and have higher mortality rates compared to those without disabilities. This is particularly true for people with intellectual and developmental disabilities, those residing in care facilities, and women with disabilities. Individuals with disabilities face heightened risks of mental health issues related to the pandemic, such as increased feelings of loneliness and isolation. They were also more likely to face domestic violence and abuse during the pandemic. People with disabilities are more likely to experience unemployment as a result of the pandemic and may require changes to the types of accommodations they require for work. Children with disabilities experience complications in their educational programming. Remote learning poses a host of challenges for children with disabilities, including disruptions to physical and occupational therapies and access to assistive technologies.

References

  1. "COVID-19 and Your Health". Centers for Disease Control and Prevention. CDC. 11 February 2020. Archived from the original on 27 August 2021. Retrieved 27 August 2021.
  2. Morris, Amanda (2021-08-09). "Families of High-Risk Children Despair Over Covid Resurgence". The New York Times. ISSN   0362-4331. Archived from the original on 2021-08-19. Retrieved 2021-08-27.
  3. 1 2 3 4 Aday, Lu Ann (2002-02-28). At Risk in America: The Health and Health Care Needs of Vulnerable Populations in the United States. John Wiley & Sons. ISBN   978-0-7879-5932-6.
  4. Summers, Nancy (2003). Fundamentals for Practice with High-risk Populations. Brooks/Cole. ISBN   978-0-534-55866-6.
  5. Forman, Samuel; Kelliher, Matthew (1999-06-29). Status One: Breakthroughs in High Risk Population Health Management. Wiley. ISBN   978-0-7879-4154-3.
  6. Banach, Je (2020-04-01). "I Am High-Risk for COVID-19—We Need to Talk". Vogue. Archived from the original on 2021-08-14. Retrieved 2021-08-27.
  7. "The Plague Year". The New Yorker. 2020-12-23. Archived from the original on 2021-08-25. Retrieved 2021-08-27.
  8. "COVID-19: Who's at higher risk of serious symptoms?". Mayo Clinic. Archived from the original on 2021-05-13. Retrieved 2021-08-27.
  9. 1 2 "Coronavirus and COVID-19: Who is at higher risk?". www.hopkinsmedicine.org. Archived from the original on 2021-07-17. Retrieved 2021-08-28.
  10. CDC (2020-02-11). "Healthcare Workers". Centers for Disease Control and Prevention. Retrieved 2021-08-28.
  11. McCarron, Robert M.; Xiong, Glen L.; Keenan, Craig R.; Nasrallah, Henry A. (2015-04-01). Preventive Medical Care in Psychiatry: A Practical Guide for Clinicians. American Psychiatric Pub. ISBN   978-1-58562-546-8.
  12. Pates, Richard; Riley, Diane (2012-05-31). Harm Reduction in Substance Use and High-Risk Behaviour. John Wiley & Sons. ISBN   978-1-118-34335-7.
  13. "HIGH-RISK FOR SEVERE COVID-19 OR COMPLICATIONS FROM COVID-19" (PDF). Archived (PDF) from the original on 2021-04-17. Retrieved 2021-08-27.
  14. Affairs (ASPA), Assistant Secretary for Public (2021-02-18). "How Do I Know if I'm High Risk, and What Do I Do Next?". combatCOVID.hhs.gov. Archived from the original on 2021-08-25. Retrieved 2021-08-27.